Catechin relieves hypoxia/reoxygenation-induced myocardial cell apoptosis via down-regulating lncRNA MIAT

Lin Cong1, Yisheng Su2, Dazhen Wei3

  • 1Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Catechin protects the heart from injury by inhibiting apoptosis. It achieves this by regulating the CREB/lncRNA MIAT/Akt/Gsk-3β pathway, offering a potential therapeutic strategy for myocardial ischemia-reperfusion injury.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Cellular Biology

Background:

  • Myocardial ischemia/reperfusion (MI/R) injury is a significant clinical concern.
  • Catechin is known to protect the heart, but its effect on H/R-induced myocardial cell apoptosis is not well understood.

Purpose of the Study:

  • To investigate the protective mechanism of catechin against H/R-induced myocardial cell apoptosis.
  • To elucidate the role of the CREB/lncRNA MIAT/Akt/Gsk-3β pathway in catechin's cardioprotective effects.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) for lncRNA MIAT expression.
  • Cell viability assays (CCK-8) and apoptosis detection (flow cytometry) in H9C2 cells.
  • Dual-luciferase reporter and ChIP assays to confirm transcription factor binding.

Main Results:

  • Catechin improved cardiac function and reduced lncRNA MIAT in MI/R rats.
  • Catechin inhibited H/R-induced apoptosis in H9C2 cells, an effect blunted by MIAT overexpression.
  • Catechin up-regulated CREB, which suppressed MIAT expression, subsequently promoting Akt/Gsk-3β activation and reducing apoptosis.

Conclusions:

  • Catechin alleviates H/R-induced myocardial cell apoptosis.
  • The mechanism involves the regulation of the CREB/lncRNA MIAT/Akt/Gsk-3β pathway.
  • This pathway presents a potential therapeutic target for managing MI/R injury.
Abstract

Related Concept Videos